Management of new onset atrial fibrillation.

Evidence report/technology assessment (Summary)

Volumn , Issue 12, 2000, Pages 1-7

  McNamara, R L ^a   Bass, E B ^a   Miller, M R ^a   Segal, J B ^a   Goodman, S N ^a   Kim, N L ^a   Robinson, K A ^a   Powe, N R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; AMBULATORY CARE; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; COMORBIDITY; DECISION SUPPORT SYSTEM; ECHOCARDIOGRAPHY; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MALE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RISK FACTOR; SEX RATIO; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CLINICAL TRIALS; COMORBIDITY; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0034189498     PISSN: 1530440X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)